Two people working in the addiction field recently gave me a question to respond to here on Recovery Review. Interestingly, they both gave me the same question. One phrased it as a topic by saying, “I would enjoy hearing some more about risk and protective factors for SUD clinicians.” The other phrased it as a question: … Continue reading Question from the field: How does someone maintain longevity in the addiction field?
Author: Brian Coon
Question from the field: “Do ACT and the unconscious have any common ground?”
This week I was asked, “What common ground is there between Acceptance and Commitment Therapy and ‘the unconscious’? And if there is any common ground, how can it apply to addiction counseling and addiction recovery?” To me, the common ground is cognitive dissonance. In my opinion, that was an interesting question. Here’s why. Acceptance and … Continue reading Question from the field: “Do ACT and the unconscious have any common ground?”
Addiction Treatment Except for Tobacco and Nicotine: A Call for Change
I've completed a monograph that calls for change in the addiction treatment arena. It focuses on our need to modify our settings and services to a tobacco-free and smoke-free model of care. Below is the Abstract followed by the full text of the monograph. Acknowledgements. I would like to thank the following people for their … Continue reading Addiction Treatment Except for Tobacco and Nicotine: A Call for Change
Tobacco-free and smoke-free addiction treatment: monograph introduction # 4
I've completed a monograph that calls for change in the addiction treatment arena. It focuses on our need to modify our settings and services to a tobacco-free and smoke-free model of care. This post is the fourth and final in a small series of excerpts from the monograph. The intent of posting these excerpts is … Continue reading Tobacco-free and smoke-free addiction treatment: monograph introduction # 4
Tobacco-free and smoke-free addiction treatment: monograph introduction # 3
I've completed a monograph that calls for change in the addiction treatment arena. It focuses on our need to modify our settings and services to a tobacco-free and smoke-free model of care. This post is the third in a small series of excerpts from the monograph. The intent of posting these excerpts is to build … Continue reading Tobacco-free and smoke-free addiction treatment: monograph introduction # 3
Tobacco-free and smoke-free addiction treatment: monograph introduction # 2
I've completed a monograph that calls for change in the addiction treatment arena. It focuses on our need to modify our settings and services to a tobacco-free and smoke-free model of care. This post is the second in a small series of excerpts from the monograph. The intent of posting these excerpts is to build … Continue reading Tobacco-free and smoke-free addiction treatment: monograph introduction # 2
Tobacco-free and smoke-free addiction treatment: monograph introduction
I've completed a monograph that calls for change in the addiction treatment arena. It focuses on our need to modify our settings and services to a tobacco-free and smoke-free model of care. This post will serve as the first in a small series of excerpts from the monograph. The intent of posting these excerpts is … Continue reading Tobacco-free and smoke-free addiction treatment: monograph introduction
JUUL E-Cigarette Products & the FDA
In case you missed it, on 07/17/2025 the FDA announced it has "authorized" the marketing of five JUUL e-cigarette products. These are the JUUL device, Virginia Tobacco flavor JUULpods (3% and 5% nicotine concentration) and Menthol flavor JUULpods (3% and 5% nicotine concentration). Give these quotes from the FDA announcement a read. Then I'll add … Continue reading JUUL E-Cigarette Products & the FDA
6-methyl nicotine is here
Did you know that a synthetic analog of nicotine has been developed and is on the market? It’s called 6-methyl nicotine (6-MN). Before we get into some of the more recent findings about 6-MN, it’s important to understand one specific term related to the research. The term is “reactive oxygen species”, or ROS. Here’s the … Continue reading 6-methyl nicotine is here
Pouch
A few days ago I posted a list of research-based findings concerning nicotine. The post was simply titled "Nicotine". One main point of that post was to ask, "On a scale from 0 to 10 how important is it to treat tobacco use in a patient with a substance use disorder? And why?" That post … Continue reading Pouch
